4
Changes in Ownership
AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001096906-22-002331
Options or other derivatives
- Chief Executive Officer acquired 5,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| HUEMOELLER JOHN WALTER II Chief Executive Officer | 2022-09-23 | Grant or award · Option | +5,000,000 | 8,000,000 | D | ||
Loading xslF345X03/form4.xml…